title: Tribute to John H. Laragh, MD.
authors.affiliation: Rogosin Institute and the Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medical College, New York. jdblume@nyp.org.
authors.forename: Jon
authors.initials: J
authors.lastname: Blumenfeld
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000266:history; D000804:Angiotensin II / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000266:history; D000959:Antihypertensive Agents / Q000266:history* / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000266:history* / Q000378:metabolism; D000451:Mineralocorticoid Receptor Antagonists / Q000266:history; D012083:Renin / Q000266:history*; D012084:Renin-Angiotensin System; D000092502:Renin Inhibitors
chemical_list: D000319:Adrenergic beta-Antagonists; D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000451:Mineralocorticoid Receptor Antagonists; D012083:Renin; D000092502:Renin Inhibitors